{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T15:46:57Z","timestamp":1648914417853},"reference-count":11,"publisher":"Akademiai Kiado Zrt.","issue":"Supplement-1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MaSeb"],"published-print":{"date-parts":[[2008,5,1]]},"abstract":"<jats:title>Absztrakt<\/jats:title>\n        <jats:p>A sz\u00edvseb\u00e9szetben a v\u00e9rz\u00e9ses sz\u00f6v\u0151dm\u00e9nyek jelent\u0151sen n\u00f6velik a korai hal\u00e1loz\u00e1st \u00e9s a kezel\u00e9si k\u00f6lts\u00e9geket. Ezeknek a sz\u00f6v\u0151dm\u00e9nyeknek a kezel\u00e9s\u00e9ben az aktiv\u00e1lt rekombin\u00e1ns faktor VII a sz\u00edvseb\u00e9szetben is fokozatosan teret nyer. A szerz\u0151k int\u00e9zet\u00e9ben 2004\u20132007 k\u00f6z\u00f6tt 11 betegn\u00e9l alkalmazt\u00e1k, akik k\u00f6z\u00fcl 9 beteg el\u0151zetesen magas kock\u00e1zat\u00fa, hossz\u00fa, aortalefog\u00e1ssal \u00e9s mesters\u00e9ges kering\u00e9si id\u0151vel j\u00e1r\u00f3 kombin\u00e1lt (billenty\u0171- \u00e9s koszor\u00fa\u00e9r-\u00e1thidal\u00e1s) m\u0171t\u00e9ten esett \u00e1t, egy esetben koszor\u00fa\u00e9r-betegs\u00e9g miatti \u00fajabb \u00e1thidal\u00e1st v\u00e9geztek, m\u00edg egy m\u00e1sik beteg aortadissectio miatt ker\u00fclt m\u0171t\u00e9tre. Az alkalmazott \u00e1tlagos adag 6,5 mg (2,4\u20139,6 mg) volt. A NovoSeven\u00ae bead\u00e1sa el\u0151tti v\u00e9rz\u00e9s \u00e1tlagosan 5440 ml, m\u00edg a gy\u00f3gyszer alkalmaz\u00e1sa ut\u00e1n a v\u00e9rz\u00e9s \u00e1tlaga 987 ml volt. A 11 betegb\u0151l 9 gy\u00f3gyultan hagyta el int\u00e9zetet, m\u00edg 2 beteg a k\u00f3rh\u00e1zi kezel\u00e9s idej\u00e9n elhunyt, r\u00e9szben a faktor megk\u00e9sett alkalmaz\u00e1sa, r\u00e9szben a s\u00falyos k\u00eds\u00e9r\u0151 betegs\u00e9gek miatt (b\u00e9lischaemia, m\u00e1jcirrhosis). K\u00f6vetkeztet\u00e9seink: A NovoSeven\u00ae megfelel\u0151 id\u0151ben \u00e9s adagban alkalmazva nagym\u00e9rt\u00e9kben cs\u00f6kkenti a sz\u00edvm\u0171t\u00e9tek sor\u00e1n fell\u00e9p\u0151, seb\u00e9szi ell\u00e1t\u00e1ssal rem\u00e9nytelennek t\u0171n\u0151 v\u00e9rz\u00e9seket. Alkalmaz\u00e1sa \u00e9letment\u0151 lehet az elh\u00faz\u00f3d\u00f3 mesters\u00e9ges kering\u00e9ssel \u00e9s hossz\u00fa aortalefog\u00e1ssal j\u00e1r\u00f3 kombin\u00e1lt, magas kock\u00e1zat\u00fa m\u0171t\u00e9teket k\u00f6vet\u0151 diff\u00faz v\u00e9rz\u00e9sekn\u00e9l, s\u0151t szakad\u00e9kony sz\u00f6vetek miatt el\u00e9gtelenn\u00e9 v\u00e1l\u00f3 varratok eset\u00e9n is l\u00e9nyegesen cs\u00f6kkenti a v\u00e9rz\u00e9st. Elk\u00e9sett vagy rem\u00e9nytelen esetekben val\u00f3 alkalmaz\u00e1sa nem javasolt, mert az \u00e1tmeneti v\u00e9rz\u00e9scs\u00f6kken\u00e9s ritk\u00e1n v\u00e1ltoztatja meg a v\u00e9gzetes k\u00f3rlefoly\u00e1st.<\/jats:p>","DOI":"10.1556\/maseb.61.2008.suppl.11","type":"journal-article","created":{"date-parts":[[2008,5,27]],"date-time":"2008-05-27T01:01:06Z","timestamp":1211850066000},"page":"45-47","source":"Crossref","is-referenced-by-count":0,"title":["Tapasztalataink a rekombin\u00e1ns faktor VIIa-val (NovoSeven\u00ae) a magas kock\u00e1zat\u00fa sz\u00edvm\u0171t\u00e9tek v\u00e9rz\u00e9ses sz\u00f6v\u0151dm\u00e9nyeinek kezel\u00e9s\u00e9benr"],"prefix":"10.1556","volume":"61","author":[{"given":"Szabolcs","family":"Miskolczi","sequence":"first","affiliation":[{"name":"1 Kardiol\u00f3giai Int\u00e9zet, Sz\u00edvseb\u00e9szeti K\u00f6zpont, Debreceni Egyetem, Orvos- \u00e9s Eg\u00e9szs\u00e9gtudom\u00e1nyi Centrum, 4032, Debrecen, M\u00f3ricz Zs. krt. 22."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikl\u00f3s","family":"Vaszily","sequence":"additional","affiliation":[{"name":"1 Kardiol\u00f3giai Int\u00e9zet, Sz\u00edvseb\u00e9szeti K\u00f6zpont, Debreceni Egyetem, Orvos- \u00e9s Eg\u00e9szs\u00e9gtudom\u00e1nyi Centrum, 4032, Debrecen, M\u00f3ricz Zs. krt. 22."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Papp","sequence":"additional","affiliation":[{"name":"2 Aneszteziol\u00f3giai \u00e9s Intenz\u00edv Ter\u00e1pi\u00e1s Tansz\u00e9k, Debreceni Egyetem, Orvos- \u00e9s Eg\u00e9szs\u00e9gtudom\u00e1nyi Centrum, Debrecen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1rp\u00e1d","family":"P\u00e9terffy","sequence":"additional","affiliation":[{"name":"1 Kardiol\u00f3giai Int\u00e9zet, Sz\u00edvseb\u00e9szeti K\u00f6zpont, Debreceni Egyetem, Orvos- \u00e9s Eg\u00e9szs\u00e9gtudom\u00e1nyi Centrum, 4032, Debrecen, M\u00f3ricz Zs. krt. 22."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"1","first-page":"586","article-title":"Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic rupture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial","volume":"94","author":"Raobaikady R","year":"2005","journal-title":"Br J Anaesth"},{"key":"2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00000542-200502000-00006","article-title":"Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial","volume":"102","author":"Lodge JP","year":"2005","journal-title":"Anaesthesiology"},{"key":"3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.STR.0000254499.46122.22","article-title":"Recombinant activated factor VII for acute intracerebral haemorrhage","volume":"38","author":"Mayer SA","year":"2007","journal-title":"Stroke"},{"key":"4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1213\/01.ane.0000209023.96418.e5","article-title":"Small-dose recombinant activated factor VII (NovoSeven) in cardiac surgery","volume":"102","author":"Romagnoli S","year":"2006","journal-title":"Anaesth Analg"},{"key":"5","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1097\/01.CCM.0000181527.47749.57","article-title":"Recombinant activated factor VII for refractory bleeding after cardiac surgery \u2013 a retrospective analysis of safety and efficacy","volume":"33","author":"Heymann C","year":"2005","journal-title":"Crit Care Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejcts.2007.10.004","article-title":"Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven\u00ae): a propensity score analysis","volume":"33","author":"Gelsomino S","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.athoracsur.2006.06.076","article-title":"Recombinant activated factor VII: treating postoperative haemorrhage in cardiac surgery","volume":"83","author":"Bishop CV","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.athoracsur.2006.05.076","article-title":"Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII","volume":"82","author":"Flisoufi F","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejcts.2005.04.021","article-title":"Recombinat activated factor VII in the management of life-threatening bleeding in cardiac surgery","volume":"28","author":"Hyllner M","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/BF03022836","article-title":"Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery","volume":"53","author":"McCall P","year":"2006","journal-title":"Can J Anaesth"},{"key":"11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1537-2995.2005.04216.x","article-title":"Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis","volume":"45","author":"Karkouti K","year":"2005","journal-title":"Transfusion"}],"container-title":["Magyar Seb\u00e9szet"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/1046\/61\/Supplement-1\/article-p45.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/maseb.61.2008.suppl.11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:58:31Z","timestamp":1590141511000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/maseb.61.2008.Suppl.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,1]]},"references-count":11,"journal-issue":{"issue":"Supplement-1"},"URL":"https:\/\/doi.org\/10.1556\/maseb.61.2008.suppl.11","relation":{},"ISSN":["0025-0295","1789-4301"],"issn-type":[{"value":"0025-0295","type":"print"},{"value":"1789-4301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,1]]}}}